InvestorsHub Logo

Investor2014

01/11/24 2:14 PM

#447286 RE: Joseph_K #447282

Not really.

Did anybody hear anything new?


But Missling explained the "hiccups" an underpowered EXCELLENCE study with enthusiasm.

bas2020

01/11/24 2:18 PM

#447291 RE: Joseph_K #447282

He spent significant time comparing efficacy of blarcamesine and ease of administration versus the mabs. That was impactful, as well as the RWE of Rett patients showing QoL improvements... in mobility and reduction of seizure frequency. Excellent qualitative addition!